Correlation Between Flora Growth and Briacell Therapeutics
Can any of the company-specific risk be diversified away by investing in both Flora Growth and Briacell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Flora Growth and Briacell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Flora Growth Corp and Briacell Therapeutics Corp, you can compare the effects of market volatilities on Flora Growth and Briacell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Flora Growth with a short position of Briacell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Flora Growth and Briacell Therapeutics.
Diversification Opportunities for Flora Growth and Briacell Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Flora and Briacell is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Flora Growth Corp and Briacell Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Briacell Therapeutics and Flora Growth is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Flora Growth Corp are associated (or correlated) with Briacell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Briacell Therapeutics has no effect on the direction of Flora Growth i.e., Flora Growth and Briacell Therapeutics go up and down completely randomly.
Pair Corralation between Flora Growth and Briacell Therapeutics
Given the investment horizon of 90 days Flora Growth Corp is expected to under-perform the Briacell Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Flora Growth Corp is 1.43 times less risky than Briacell Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Briacell Therapeutics Corp is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 65.00 in Briacell Therapeutics Corp on September 20, 2024 and sell it today you would lose (6.00) from holding Briacell Therapeutics Corp or give up 9.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Flora Growth Corp vs. Briacell Therapeutics Corp
Performance |
Timeline |
Flora Growth Corp |
Briacell Therapeutics |
Flora Growth and Briacell Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Flora Growth and Briacell Therapeutics
The main advantage of trading using opposite Flora Growth and Briacell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Flora Growth position performs unexpectedly, Briacell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Briacell Therapeutics will offset losses from the drop in Briacell Therapeutics' long position.Flora Growth vs. Clever Leaves Holdings | Flora Growth vs. Painreform | Flora Growth vs. INC Research Holdings | Flora Growth vs. Lowell Farms |
Briacell Therapeutics vs. X4 Pharmaceuticals | Briacell Therapeutics vs. Terns Pharmaceuticals | Briacell Therapeutics vs. Day One Biopharmaceuticals | Briacell Therapeutics vs. PDS Biotechnology Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |